Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-06-04
1997-10-28
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, A61K 3800, A01N 3718
Patent
active
056818149
ABSTRACT:
A formulation for IGF-I is disclosed that is useful in treating hyperglycemic disorders and, in combination with growth hormone, in enhancing growth of a mammal. Also disclosed is a process for preparing a formulation of growth hormone and IGF-I from the IGF-I formulation. The IGF-I formulation comprises about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH 5-5.5, optionally with a surfactant.
REFERENCES:
patent: 4609640 (1986-09-01), Morishita et al.
patent: 4857505 (1989-08-01), Arendt
patent: 4988675 (1991-01-01), Froesch
patent: 5126324 (1992-06-01), Clark
patent: 5187151 (1993-02-01), Clark et al.
The Merck Index, 11th edition, ed. Susan Budavari (Merck & Co., Inc., Rahway, NJ 1989), p. 49.
Merck Index, 11th ed. p. 1207.
J. Zapf et al., J. Clin. Inv., 77, 1768-1775 (1986).
Guler et al., "S.C. Infusion of Recombinant Human Insulin-like Growth Factor I (rhIGF I) Stimulates Growth of Hypophysectomized Rats Continously During 18 Days", 1st European Congress of Endocrinology, Copenhagen, Jensen & Christiansen, eds., 103:12-390, (Jun. 21-25, 1987).
Guler et al. "Effects of recombinant insulin-Like growth factor I on insulin secretion and renal function in normal human subjects", Proc. Natl. Acad. Sci. USA, 86: 2868-2872 (1989).
Schoenle et al., "Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats", Acta Endocrin., 108: 167-174 (1985).
Skottner et al., "Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats", J. Endocr., 112: 123-132 (1987).
Skottner et al., "Growth Responses in a Mutant Dwarf Rat to Human Growth Hormone and Recombinant Human Insulin-Like Growth Factor I", Endocrinology, 124(5): 2519-2526 (1989).
Tanner et al., "Comparative rapidity of response of height, limb muscle, and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency", Acta Endocrinol., 84: 681-696 (1977).
Uthne et al., "Effects of Human Somatomedin Preparations on Membrane Transport and Protein Synthesis in the Isolated Rat Diaphragm", J. Clin. Endocrinol. Metab., 39: 548-554 (1974).
Guler et al., "Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults", N. Engl. J. Med., 317(3): 137-140 (1987).
Guler et al., "IGF I and II and recombinant human (RH) IGF I are hypoglycemic in the rat, mini-pig and men", The Endocrine Society, 68th Annual Mtg, #394, (1986).
Guler et al., "Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats", Proc. Natl. Acad. Sci. USA, 85: 4889-4893 (1988).
Froesch et al., "IGF I and II: in vitro and in vivo effects", Endocrinology, Intl. Congress Series 655, Labrie and Proulx, eds. Amsterdam: Excerpta Medica, 475-479 (1984).
Scheiwiller et al., "Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I", Nature, 323: 169-171 (1986).
van Buul-Offers et al., "Biosynthetic Somatomedin C(SM-C/IGF-I) Increases the Length and Weight of Snell Dwarf Mice", Pediatr. Res., 20(9): 825-827 (1986).
Niall, "Revised Primary Structure for Human Growth Hormone", Nature, New Biology, 230(11): 90-91 (1971).
Moore et al., "Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine", Endocrinology, 122(6): 2920-2926 (1988).
Kaplan, Growth Disorders in Children and Adolescents 47-69, 131-139, 165-169 (Springfield, IL: Charles C. Thomas, 1964).
Salmon and Daughaday, "A Hormonally Controlled Serum Factor Which Stimulates Sulfate Incorporation by Cartilage In Vitro", J. Lab. Clin. Med., 49(6): 825-836 (1957).
Phillips & Vassilopoulou-Sellin, "Somatomedins", (First of Two Parts), N. Engl. J. Med., 302(7): 371-380 (Feb. 14, 1980).
Phillips & Vassilopoulou-Sellin, "Somatomedins", (Second of Two Parts), N. Engl. J. Med., 302(8): 438-446 (Feb. 21, 1980).
Vetter et al., "Human Fetal and Adult Chondrocytes: Effects of insulinlike growth factors I and II, insulin and growth hormone on clonal growth", J. Clin. Invest., 7: 1903-1908 (1986).
Cook et al., "Mitogenic Effects of Growth Hormone in Cultured Human Fibroblasts", J. Clin. Invest., 81: 206-212 (1988).
Isgaard et al., "Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion", Endocrinology, 123(6): 2605-2610 (1988).
Isaksson et al., "Growth hormone stimulates longitudinal bone growth directly", Science, 216: 1237-1239 (1982).
Russell and Spencer, "Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats", Endocrinology, 116(6): 2563-2567 (1985).
Schlechter et al., "A direct growth effect of growth hormone in rat hindlimb shown by arterial infusiion", Am. J. Physiol., 250: E231-235 (1986).
Madsen et al., "Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage", Nature, 304: 545-547 (1983).
Schlechter et al., "Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin", Proc. Natl. Acad. Sci. USA, 83: 7932-7934 (1986).
Nilsson et al., "Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats", Calcif. Tissue Int., 40: 91-96 (1987).
Otonkoski et al., "Effects of growth hormone and insulin-like growth factor I on endocrine function of human fetal islet-like cell clusters during long-term tissue culture", Diabetes, 37: 1678-1683 (1988).
Green et al., "A dual effector theory of growth-hormone action", Differentation, 29: 195-198 (1985).
Zezulak and Green, "The Generation of Insulin-Like Growth Factor-1-Sensitive Cells by Growth Hormone Action", Science, 233: 551-553 (1986).
Young et al., "Growth hormone and testosterone can independently stimulate the growth of hypophysectomized prepubertal lambs without any alteration in circulating concentrations of insulin-like growth factors", J. Endocrin.,121: 563-570 (1989).
Orlowski and Chernausek, "Discordance of Serum and Tissue Somatomedin Levels in Growth Hormone-Stimulated Growth in the Rat", Endocrinol., 123(1): 44-49 (1988).
Trippel et al., "Effect of Somatomedin-C/Insulin-Like Growth Factor I and Growth Hormone on Cultured Growth Plate and Articular Chondrocytes", Pediatr. Res., 25(1): 76-82 (1989).
Isgaard et al., "Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats", Am. J. Physiol., 250: E367-E372 (1986).
Robinson and Clark, "Growth Promoting Activity of IGF-1 in the Rat", Acta Paediatr. Scand. Supp., 347: 93-103 (1988).
Ernst and Froesch, "Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I," Biochem. Biophy. Res. Commun., 151(1): 142-147 (1988).
Smith et al., "Growth Hormone Stimulates Insulin-like Growth Factor I Actions on Adult Articular Chondrocytes", J. Orthop. Res., 7: 198-207 (1989).
Merchav et al., "Enhancement of Human Granulopoiesis In Vitro by Biosynthetic Insulin-like Growth Factor I/Somatomedin C and Human Growth Hormone", J. Clin. Invest., 81: 791-797 (1988).
Lobie et al., "Growth Hormone Receptor Expression in the Rat Gastrointestinal Tract", Endocrinol., 126: 299-306 (1990).
Lindahl et al., "Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 on colony in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats", Endocrinol., 121(3): 1070-075 (1987).
van Neste et al., "Cellular distribution of somatogenic receptors and insulin-like growth factor-I mRNA in the rat liver", J. Endocr., 199: 69-74 (1988).
Namba et al., "Insulin-Like Growth Factor-I Action on Growth Hormone Secretion and Messenger Ribonucleic Acid Le
Clark Ross G.
Oeswein James Q.
Yeung Douglas A.
Genentech Inc.
Hasak Janet E.
Huff Sheela J.
Scheiner Toni R.
LandOfFree
Formulated IGF-I Composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulated IGF-I Composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulated IGF-I Composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026140